I 
118TH CONGRESS 
1ST SESSION H. R. 4105 
To amend the Controlled Substances Act to prohibit certain acts related 
to fentanyl, analogues of fentanyl, and counterfeit substances, and for 
other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
JUNE 14, 2023 
Mr. BUCK (for himself, Mr. JOYCE of Ohio, Mr. STANTON, and Mr. CORREA) 
introduced the following bill; which was referred to the Committee on the 
Judiciary, and in addition to the Committee on Energy and Commerce, 
for a period to be subsequently determined by the Speaker, in each case 
for consideration of such provisions as fall within the jurisdiction of the 
committee concerned 
A BILL 
To amend the Controlled Substances Act to prohibit certain 
acts related to fentanyl, analogues of fentanyl, and coun-
terfeit substances, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Stop Pills That Kill 
Act’’. 
VerDate Sep 11 2014 
04:55 Jul 15, 2023
Jkt 039200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H4105.IH
H4105
pbinns on DSKJLVW7X2PROD with $$_JOB
SEC. 2. DEFINITION. 
In this Act, the term ‘‘counterfeit fentanyl or meth-
amphetamine substance’’ means a substance that— 
(1) contains fentanyl, any analogue of fentanyl, 
or methamphetamine; and 
(2) is marketed, sold, or falsely bears the trade-
mark, trade name, or other identifying mark, im-
print, number, or any likeness thereof of another 
product. 
SEC. 3. PROHIBITED ACTS. 
Section 403(d)(2) of the Controlled Substances Act 
(21 U.S.C. 843(d)(2)) is amended, in the matter pre-
ceding subparagraph (A), by inserting ‘‘, fentanyl, an ana-
logue of fentanyl, or a counterfeit substance’’ after ‘‘meth-
amphetamine’’. 
SEC. 4. COMPREHENSIVE PLAN. 
Not later than 180 days after the date of enactment 
of this Act, the Administrator of the Drug Enforcement 
Administration shall establish and implement an operation 
and response plan to address counterfeit fentanyl or meth-
amphetamine substances that includes— 
(1) strategies to enable and empower Federal 
law enforcement efforts to investigate and seize 
counterfeit fentanyl or methamphetamine sub-
stances; 
VerDate Sep 11 2014 
04:55 Jul 15, 2023
Jkt 039200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H4105.IH
H4105
pbinns on DSKJLVW7X2PROD with $$_JOB
(2) specific ways that education and prevention 
efforts to stop the use of counterfeit fentanyl or 
methamphetamine substances will be increased, in-
cluding how— 
(A) ongoing efforts, such as Operation En-
gage, are effective in increasing education and 
prevention; and 
(B) how the efforts described in subpara-
graph (A) are tailored to youth and teen access; 
and 
(3) an audit of current campaigns, including 
the ‘‘One Pill Can Kill’’ campaign, on counterfeit 
fentanyl or methamphetamine substances, including 
a review of data and other available information on 
how the campaigns can be tailored, adjusted, or im-
proved to better address the flow of counterfeit 
fentanyl or methamphetamine substances. 
SEC. 5. REPORT TO CONGRESS. 
(a) REPORT.—Not later than 1 year after the date 
of enactment of this Act, and every year thereafter, the 
Attorney General, in consultation with the Administrator 
of the Drug Enforcement Administration and Director of 
the Office of National Drug Control Policy, shall submit 
to Congress a report on information regarding the collec-
VerDate Sep 11 2014 
04:55 Jul 15, 2023
Jkt 039200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H4105.IH
H4105
pbinns on DSKJLVW7X2PROD with $$_JOB
tion and prosecutions of counterfeit fentanyl or meth-
amphetamine substances. 
(b) CONTENTS.—The report required under sub-
section (a) shall include the following: 
(1) Data on the aggregate number of counter-
feit fentanyl or methamphetamine substances seized 
and collected by Federal law enforcement agencies. 
(2) A breakdown on how many counterfeit 
fentanyl or methamphetamine substances are in pill 
form. 
(3) A breakdown on which illicit substances are 
present in the counterfeit fentanyl or methamphet-
amine substances that are in pill form. 
(4) Data outlining where and when counterfeit 
fentanyl or methamphetamine substances were 
seized. 
(5) Data on the charges filed against those 
manufacturing, distributing, or dispensing, or pos-
sessing with the intent to distribute or dispense, a 
counterfeit fentanyl or methamphetamine substance, 
particularly in pill form, pursuant to paragraph (1) 
or (2) of section 401(a) of the Controlled Substances 
Act (21 U.S.C. 841(a)), unless disclosure of the data 
would— 
(A) require unsealing an indictment; or 
VerDate Sep 11 2014 
04:55 Jul 15, 2023
Jkt 039200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H4105.IH
H4105
pbinns on DSKJLVW7X2PROD with $$_JOB
(B) undermine investigations and charges 
brought by the Department of Justice. 
(6) Data on the convictions and sentences 
against those who are found guilty under paragraph 
(1) or (2) of section 401(a) of the Controlled Sub-
stances Act (21 U.S.C. 841(a)) as it pertains to 
counterfeit fentanyl or methamphetamine sub-
stances, particularly those in pill form. 
(7) Any prevention measures that the Depart-
ment of Justice, Drug Enforcement Administration, 
or Office of National Drug Control Policy are under-
taking to limit and reduce the spread of counterfeit 
fentanyl or methamphetamine substances in pill 
form, including ongoing public awareness campaigns. 
Æ 
VerDate Sep 11 2014 
04:55 Jul 15, 2023
Jkt 039200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H4105.IH
H4105
pbinns on DSKJLVW7X2PROD with $$_JOB